Animal studies
showed antagonistic effects of pindolol at 5-HT1A sematodentritic autoreceptors
and lack of antagonism at postsynaptic 5-HT 1A receptors in the hippocampus.
Pindolol was shown
to prevent the inhibitory effect of paroxetine on the firing activity
of 5-HT neurons.
Pindololís
safety and therapeutic potential as an augmenting agent was corroborated
by investigators.